The Coredio app showing hemodynamic readings on a phone and smartwatch

Noninvasive hemodynamic insight

for heart failure care

Request a Demo

Coredio estimates the pressures and blood flow inside the heart from wearables, using AI and a digital twin of each patient.

FDA

Breakthrough Device Designation

Granted

March
2026

What Coredio is

Coredio CPSE, the Cardiac Performance Simulation Engine, builds a digital twin of each patient’s heart and circulation,

turning everyday wearable data into the heart measurements clinicians use to guide treatment. No implant. No procedure..

  • Physics-based digital twin
  • Trained on clinical data
  • Watch and cuff inputs
  • LVEDP, CVP, CI, SVR

The challenge with the current standard of care

Heart monitoring today is fragmented, costly, and invasive

A clinician reviewing heart failure data at a desk

Too little monitoring

Heart failure care still has no good standard for day-to-day monitoring.

Patients waiting to be seen by a clinician

Limited access between visits

Without an echo or cath, care teams can't see how the heart is really doing.

A clinician at the bedside of a hospital patient

Invasive and costly

Getting accurate data at home today means an expensive implant.

Our platform

Personalized heart monitoring with no implant, built on AI, digital twins, and everyday wearables.

  • Patient eligibility

  • Quick personalization

  • At-home checks

Data collection

Live heart data from a watch and cuff.

A smartwatch measuring heart signals

Clear insight

Clear analysis that helps care teams decide what to do next.

The Coredio clinician dashboard

CPSE Algorithm

Turns heart data into numbers clinicians can use.

CPSE, the Cardiac Performance Simulation Engine
Real-time hemodynamic readings

Hemodynamic status

Real-time blood flow & vitals.

Our solution

Catheter-grade heart data, anywhere the patient is.

A cross-section of the heart showing where each measure is taken
  • CVP

    Central Venous Pressure (CVP) shows fluid overload or right heart strain, an early sign a patient is getting worse.

  • SVR

    High Systemic Vascular Resistance (SVR) makes the heart work harder and pump less, a sign heart failure is getting worse.

  • LVEDP

    Left Ventricular End-Diastolic Pressure (LVEDP) predicts worsening heart failure before symptoms start.

  • CI

    Cardiac Index (CI) is blood flow adjusted for body size. It shows whether the body is getting the blood it needs.

How monitoring works

A simple workflow that fits into the care teams already provide

An illustration of the heart and circulatory system
A clinician shaking hands with a patient at a home setup visitA patient checking her smartwatch at homeA clinician reviewing results on a tablet with a patient

Personal setup

Before discharge, Coredio builds a personal model of the patient's heart in a few minutes.

Our ecosystem

A connected ecosystem that is rigorous for clinicians and simple for patients.

The Coredio smartwatch
A blood pressure cuff
The clinician dashboard
Smartwatch
Phone
Clinician monitor
CPSE at the center of the ecosystem

What clinicians say

Built for every step of heart failure care

“Coredio’s wearable-derived signals and physics-informed AI could help close the gap between hospital-based measurements and at-home heart failure monitoring, giving clinicians earlier visibility into patient physiology. FDA Breakthrough Device Designation reflects the clinical need this technology addresses.”

Dr. Jagmeet P. Singh, MGH

Mass General Brigham

Frequently asked questions

The Coredio app showing a patient's health metrics
A blood pressure cuff

A compatible smartwatch and a blood pressure cuff. If you do not already have a watch, we provide one as part of the home setup.

Connect with the Coredio team

Join the clinicians exploring a better way to monitor heart failure

FDA | Disclaimer:

Coredio CPSE™ has received FDA Breakthrough Device Designation. The device is not yet cleared by the FDA for commercial use. Indications for Use are subject to FDA review under the 510(k) process.